| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥18.77B | +10.0% |
| Gross profit | ¥2.10B | — |
| Operating income | ¥1.76B | — |
| Net income | ¥1.36B | +62.1% |
| Gross margin | 11.2% | Net margin 7.3% |
| Revenue Q/Q | -11.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥16.67B | 88.8% |
| R&D | ¥0.06B | 0.3% |
| SG&A | ¥0.37B | 2.0% |
| Tax & other | ¥0.40B | 2.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
恒瑞医药 ・ 万华化学 ・ 恒力石化 ・ 江西铜业 ・ 中航机载 ・ 国电南瑞 ・ 小商品城 ・ 华鲁恒升 ・ 片仔癀 ・ 通威股份 ・ 士兰微 ・ 中国动力
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies